Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 43.78
+1.52 (3.60%)
May 7, 2026, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 16.11 billion as of May 7, 2026. Its market cap has increased by 33.63% in one year.
Market Cap
16.11B
Enterprise Value
15.58B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.78
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 16.11B, an increase of 112.36%. That is a compound annual growth rate of 12.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 15.55B | -19.12% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 24.31B |
| Keymed Biosciences | 21.79B |
| TransThera Sciences (Nanjing) | 21.54B |
| Zai Lab | 18.68B |
| Ascletis Pharma | 17.74B |
| Nanjing Leads Biolabs | 15.59B |
| CStone Pharmaceuticals | 15.06B |
| Everest Medicines | 12.09B |